4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
BeyondSpring Inc. (BYSI) operates in the Biotechnology industry and is headquartered in Florham Park, United States with about 44 employees. Its market capitalization is roughly $55 million. In the fiscal year ended 2025-12-31, BYSI reported $0M in revenue and ($1M) in net income.
BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology. The company operates through two segments: the Plinabulin pipeline and the TPD platform.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $1M | — |
| Operating Income (EBIT) | ($9M) | ($9M) | ($15M) | ($37M) | — |
| Net Income | ($1M) | ($11M) | ($21M) | ($33M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($2M) | ($3M) | ($2M) | ($2M) | ($3M) | — |
| Net Income | ($2M) | ($2M) | ($2M) | ($2M) | $4M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $26M | $34M | $25M | $46M | — |
| Total Liabilities | $50M | $49M | $48M | $49M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BYSI viewer.
About TickerBase · Data methodology & sources